| 000 | 01391 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250513090049.0 | ||
| 264 | 0 | _c19960528 | |
| 008 | 199605s 0 0 eng d | ||
| 022 | _a0003-4819 | ||
| 024 | 7 |
_a10.7326/0003-4819-124-10-199605150-00008 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSchulman, K A | |
| 245 | 0 | 0 |
_aThe effect of pharmaceutical benefits managers: is it being evaluated? _h[electronic resource] |
| 260 |
_bAnnals of internal medicine _cMay 1996 |
||
| 300 |
_a906-13 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministrative Personnel |
| 650 | 0 | 4 | _aCase Management |
| 650 | 0 | 4 | _aConflict of Interest |
| 650 | 0 | 4 | _aData Collection |
| 650 | 0 | 4 | _aDrug Industry |
| 650 | 0 | 4 | _aDrug Utilization Review |
| 650 | 0 | 4 | _aFormularies as Topic |
| 650 | 0 | 4 |
_aHealth Benefit Plans, Employee _xstatistics & numerical data |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInsurance, Pharmaceutical Services _xstandards |
| 650 | 0 | 4 | _aManaged Care Programs |
| 650 | 0 | 4 | _aPersuasive Communication |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aRubenstein, L E | |
| 700 | 1 | _aAbernethy, D R | |
| 700 | 1 | _aSeils, D M | |
| 700 | 1 | _aSulmasy, D P | |
| 773 | 0 |
_tAnnals of internal medicine _gvol. 124 _gno. 10 _gp. 906-13 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.7326/0003-4819-124-10-199605150-00008 _zAvailable from publisher's website |
| 999 |
_c8609968 _d8609968 |
||